Cosmos Health director awarded 20K shares
Cosmos Health Inc. director and secretary Demetrios G. Demetriades received an award of 20,000 shares of common stock at $0.283 per share as equity compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cosmos Health Inc. director and secretary Demetrios G. Demetriades received an award of 20,000 shares of common stock at $0.283 per share as equity compensation. The grant came from the 2024 & 2025 Omnibus Incentive Plan, converting 20,000 vested RSUs into common shares and bringing his direct holdings to 55,000 shares.
Insider Trade Summary
20,000 shares exercised/converted
Exercise
2 txns
Insider
Demetriades Demetrios G.
Role
Secretary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Restricted Stock Unit | 20,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $.001 | 20,000 | $0.283 | $6K |
Holdings After Transaction:
Restricted Stock Unit — 0 contracts (Direct);
Common Stock, par value $.001 — 55,000 shares (Direct)
Footnotes (2)
- F1. Reflects the award of 20,000 shares of Common Stock granted on May 19, 2026, pursuant to the Issuer's 2024 & 2025 Omnibus Incentive Plan, in a transaction exempt under Rule 16b-3.
- F2. The RSUs were granted on May 19, 2026, under the Issuer's 2024 & 2025 Omnibus Incentive Plan and vested on the date of the grant, in a transaction exempt under Rule 16b-3.
Key Figures
Equity grant size: 20,000 shares
Grant price per share: $0.283 per share
Post-transaction holdings: 55,000 shares
+2 more
5 metrics
Equity grant size
20,000 shares
Common stock awarded as compensation
Grant price per share
$0.283 per share
Recorded transaction price for common stock award
Post-transaction holdings
55,000 shares
Direct common stock held after transactions
RSUs converted
20,000 RSUs
Restricted Stock Units converted into common stock
RSU conversion price
$0.00 per unit
Conversion of RSUs into common stock
Key Terms
Restricted Stock Unit, Omnibus Incentive Plan, Rule 16b-3, derivative security
4 terms
Restricted Stock Unit financial
"The 20,000 Restricted Stock Units were converted into 20,000 common shares"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Omnibus Incentive Plan financial
"under the Issuer's 2024 & 2025 Omnibus Incentive Plan and vested on the date"
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
Rule 16b-3 regulatory
"in a transaction exempt under Rule 16b-3"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
derivative security financial
"Conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Cosmos Health (COSM) report for Demetriades?
Cosmos Health reported that director and secretary Demetrius G. Demetriades received an award of 20,000 common shares. These were issued as equity compensation by converting previously granted RSUs into common stock under the company’s 2024 & 2025 Omnibus Incentive Plan.
Was the Cosmos Health (COSM) insider transaction a market purchase or compensation grant?
The transaction was a compensation-related grant, not an open-market purchase. Demetriades received 20,000 common shares at $0.283 per share through the company’s 2024 & 2025 Omnibus Incentive Plan, reflecting a grant and RSU conversion exempt under Rule 16b-3.
What happened to the 20,000 RSUs reported in the Cosmos Health (COSM) Form 4?
The 20,000 Restricted Stock Units were converted into 20,000 common shares at a $0.00 conversion price. The RSUs were granted and vested on May 19, 2026, under the 2024 & 2025 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3.
AI-generated analysis. How Rhea-AI works. Not financial advice.
